Prevention | Page 9 | Alzheimer's Prevention Registry

You are here


Brain Scans Prevent Alzheimer’s Misdiagnosis and Lead to Better Treatment—But They’re Not Covered By Medicare

An under-utilized tool could help correctly diagnose and manage dementia, leading to better care, according to a new study.

The study, published in the Journal of the American Medical Association (JAMA), found that giving patients a PET scan to get more information about the state of their brains resulted in an altered diagnosis for one in three study participants with dementia or memory problems and changed managment—medications, therapy, counseling, etc.—in two-thirds of patients.

Every senior needs cognitive screening, Alzheimer's Association says

At first, she just forgot a name or two. Then, a few meetings on her schedule. A few months later, LuPita Gutierrez-Parker found herself struggling at work to use computer software she knew intimately.

Biogen Ends Late-Stage Alzheimer’s Trials, Crushing Hopes and Calling Amyloid Into Question

Clinical trial participants, researchers and investors were reeling on Thursday after Biogen and Eisai, its Japanese pharmaceutical partner, announced that they would be halting two Stage 3 clinical trials that had previously reported positive results. Biogen said the drug, aducanumab, was unlikely to help patients.

Dementia Deaths Have More Than Doubled, According to Report. Here’s What Can Be Done

Dementia is steadily rising in the ranks of causes of death in America, according to a new report released by the National Center for Health Statistics. The most sobering statistic: The rate of Americans who died from dementia has increased from 30.5 deaths per 100,000 people in 2000 to 66.7 in 2017, more than doubling in less than twenty years.

An Alzheimer’s Drug Trial Gave Me Hope, and Then It Ended

I was a small piece in the search to find a cure. Now I feel as if I’m getting erased, and medical science doesn’t have any answers.

Supplements won't stave off Alzheimer's, doctors warn

As Alzheimer’s disease and dementia affect a growing number of Americans, efforts to keep brain decline at bay have become big business.

But in a piece published in the Journal of the American Medical Association, neurologists at the University of California, San Francisco’s Memory and Aging Center, caution consumers that brain health supplements have no proven benefit, calling them “pseudomedicine.”

Failed Alzheimer’s trial leaves families and patients heartbroken. Medical community reels

Every month, a car would pick up Jeff Borghoff at his home in Forked River, New Jersey, and drive him to the Advanced Memory Research Institute of New Jersey. There, doctors would help him settle into a comfortable chair and hook him up to an IV.

10 Years After Alzheimer's Report: Any Progress?

Navigating the chaos inside our garage this winter, I stumbled on a box brimming with artifacts from my 40-odd years as a Washington journalist. Staring back at me was the cover of one of those blue-ribbon commission reports, the kind that are collecting dust all over the nation’s capital. But this one, A National Alzheimer’s Strategic Plan: The Report of the Alzheimer’s Study Group. released 10 years ago today, was different. It not only set in motion some important policy changes; it was very personal.


Having cousins and great-grandparents with Alzheimer’s has been linked to a higher risk of developing the disease, according to a study. Scientists looked at the data on over 278,818 people included in the Utah Population Database, stretching back to the 1880s, for their work published in the journal Neurology. The participants were connected to the state's pioneers by at least three generations.

Alzheimer’s disease continues to be a growing problem

Statistics by themselves can sometimes be confusing or open to misinterpretation, so LifeTimes talked to an expert on Alzheimer’s disease about the latest numbers from the Alzheimer’s Association. We asked Dr. Amanda Smith, assistant professor of psychiatry and behavioral neurosciences and director of clinical research at the USF Health Byrd Alzheimer’s Institute in Tampa, to put the 2019 statistics into perspective. We also asked her what more positive news there might be in the near future.